Lugar de publicación Increased concentration of plasminogen activator inhibitor-1 and fibrinogen in individuals with metabolic syndrome. 2(2):253-257. 2009 Increased concentrations of soluble vascular cell adhesion molecule-1 and soluble CD40L in subjects with metabolic syndrome. 2(3):481-485. 2009
